Clinical trials
Completed Dry Eye Syndromes trials with no applicable phase
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
329 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2003 | 1 |
| 2004 | 1 |
| 2005 | 3 |
| 2006 | 3 |
| 2007 | 8 |
| 2008 | 12 |
| 2009 | 10 |
| 2010 | 15 |
| 2011 | 9 |
| 2012 | 10 |
| 2013 | 13 |
| 2014 | 9 |
| 2015 | 16 |
| 2016 | 16 |
| 2017 | 21 |
| 2018 | 23 |
| 2019 | 24 |
| 2020 | 16 |
| 2021 | 22 |
| 2022 | 32 |
| 2023 | 27 |
| 2024 | 23 |
| 2025 | 10 |
| 2026 | 4 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 329 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Alcon Research | 58 |
| Allergan | 9 |
| Singapore National Eye Centre | 8 |
| C.O.C. Farmaceutici S.r.l. | 7 |
| Oculeve, Inc. | 7 |
| University of Waterloo | 7 |
| Laboratoires Thea | 6 |
| Lumenis Be Ltd. | 6 |
| Medical University of Vienna | 6 |
| University of Alabama at Birmingham | 6 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Dry Eye Syndromes | 329 |
| Meibomian Gland Dysfunction | 49 |
| Asthenopia | 10 |
| Keratoconjunctivitis Sicca | 10 |
| Cataract | 7 |
| Sjogren's Syndrome | 7 |
| Corneal Diseases | 5 |
| Blepharitis | 4 |
| Lacerations | 4 |
| Eye Diseases | 3 |
Trials
Showing 1 to 25 of 329. Each trial links to its page on Pharma Observatory.
229 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.